Skip to main content

Home/ Medicine & Healthcare/ Group items tagged outcome

Rss Feed Group items tagged

avivajazz  jazzaviva

Management of superficial basal cell carcinoma: focus on imiquimod - 0 views

  •  
    There is reasonable evidence that the use of imiquimod for small (<2 cm) superficial BCC that occur other than on the face provides outcomes only marginally less satisfactory than surgery. There would be a place for imiquimod in treating patients with frequent multiple primary lesions when access to surgery is difficult or where clinical judgment may be influenced by patient factors as reported in some of the studies, eg, where patients may have contraindications to surgery.  It was noted that if recurrences occurred in this study they mostly occurred during the first 9 months after the end of treatment. The initial response was therefore predictive of long-term outcome so these authors recommend and encourage continued monitoring of skin lesions.
avivajazz  jazzaviva

Health Care Spending, Quality and Outcomes | Dartmouth Atlas of Health Care - 0 views

  •  
    Health Care Spending, Quality and Outcomes
avivajazz  jazzaviva

Medical News: Study Finds Flaws in Trial Registration, Selective Reporting - 0 views

  •  
    Fewer than half of all clinical trials recently published in journals with high impact factors are adequately registered, and about a third of those that are registered properly show discrepancies between the registered primary outcome and the one that actually gets reported.
avivajazz  jazzaviva

Efficacy of Aldara® (Imiquimod) for Treatment of Low-Risk Nodular Basal Cell ... - 0 views

  •  
    Aldara® can eradicate 64% of low-risk nodular basal cell carcinomas.
avivajazz  jazzaviva

Recurrence rate of superficial basal cell carcinom... [Eur J Dermatol. 2008 Nov-Dec] - ... - 0 views

  •  
    The estimate of overall treatment success for all treated patients at the end of follow-up was 77.9% (80.9% considering histology). The data support clinical assessment of initial response as predictive of long-term outcome. Most of the recurrences occurred early, indicating that careful follow-up is important during the first year after treatment.
avivajazz  jazzaviva

Management of superficial basal cell carcinoma: focus on imiquimod ~ 2009 - 0 views

  •  
    Raasch B. Clinical, Cosmetic and Investigational Dermatology. 9 June 2009.  There is reasonable evidence that the use of imiquimod for small (<2 cm) superficial BCC that occur other than on the face provides  outcomes only marginally less satisfactory t
avivajazz  jazzaviva

Management of superficial basal cell carcinoma: fo... [Clin Cosmet Investig Dermatol. 2... - 0 views

  •  
    To date one long-term study indicates a treatment success rate of 78%-81% and that initial response is a predictor of long-term outcome. Recurrences tend to occur within the first year after treatment. Future research will compare this preparation to the gold standard treatment for superficial BCC - surgical excision.
avivajazz  jazzaviva

Forum Discussion: Please Explain the Benefits of Government-Run Healthcare (the Public ... - 0 views

  •  
    I've contributed a lot to this discussion.  Perhaps I've been obssessive.  I'm concerned about the state of healthcare in this country, though.  I'm upset about the rampant myths and lies being tossed around about healthcare reform.  I'm concerned about all the lazy thinking we citizens are exhibiting. Misinformation, misunderstandings, bias, prejudice, narrowly self-interested polemics, anger, manipulations, and nastiness are badly hurting the process (and probable outcome) of healthcare reform debates and efforts. I can't NOT write long, detailed comments when I read stuff that's...well...WHACK!
avivajazz  jazzaviva

AARP |:| Fixing US Healthcare - 0 views

  •  
    The AARP just met with the leadership of the Mayo Clinic, one of the most outstanding medical institutions in the country. They provide excellent care at a cost that is less than most other parts of the healthcare system - and with improved outcomes. We asked them about their secret to success.\n\nMayo has an electronic medical record and all their patients have their information online. The physicians are on salary, so there's no incentive to order unnecessary tests or procedures, and Mayo has an ethic of patient-centered care, with a long history of attracting the best people and rewarding them.\n\nIf Mayo can do it, why can't everyone else? The AARP believes that the potential is there for most communities to have excellent care - we must emulate the care delivery of institutions like the Mayo Clinic, and put in place payment and information systems that will coordinate care management better. It's a big job and will take some investment, but we have many opportunities to do a better job than we're doing today.
avivajazz  jazzaviva

Mohs surgery in sBCC following treatment with imiquimod 5% cream - 0 views

  •  
    Eight of nine individuals, 89% (95% CI 56% to 97%) were histologically clear of sBCC at 52 weeks.
avivajazz  jazzaviva

Nonsurgical Treatment Options for Basal Cell Carcinoma | Review Article | Journal of Sk... - 0 views

  •  
    Journal of Skin CancerVolume 2011 (2011), Article ID 571734, 6 pagesdoi:10.1155/2011/571734 © 2011 Mary H. Lien and Vernon K. Sondak.
1 - 20 of 34 Next ›
Showing 20 items per page